CDER Director Janet Woodcock on new drug safety strategies

CurrentMedicine.TV interviewed Dr. Janet Woodcock, long-time Director of CDER, the FDA center responsible for approving drugs and monitoring for safety. In Part 1, she reviews her responsibilities as Director over a period of time spanning both Republican and Democratic administrations. The recent ACA healthcare reform law and the 2007 FDAAA have radically changed how the FDA is handling safety of drugs.


No Comments

No comments yet.

RSS feed for comments on this post. TrackBack URI

Leave a comment

WordPress Themes